Contact Us    855-RIA-PLAN (855-742-7526)

BMY: Bristol-Myers Squibb Co Stock

By | July 6, 2018

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 125,476.53
Enterprise Value ($M) 156,749.53
Book Value ($M) 37,284.00
Book Value / Share 16.80
Price / Book 3.37
NCAV ($M) -42,166.00
NCAV / Share -19.00
Price / NCAV -2.98

Profitability (mra)
Return on Invested Capital (ROIC) -0.07
Return on Assets (ROA) -0.04
Return on Equity (ROE) -0.11

Liquidity (mrq)
Quick Ratio 1.36
Current Ratio 1.47

Balance Sheet (mrq) ($M)
Current Assets 31,443.00
Assets 110,893.00
Liabilities 73,609.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-10 13G/A Vanguard Group Inc 8.82 2.30
01-29 13G/A BlackRock Inc. 7.60 0.65

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2021-10-27 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ☐ TRANSITION REPORT PURSUANT
2021-07-28 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ☐ TRANSITION REPORT PURSUANT TO S
2021-04-29 10-Q Quarterly Report – 10-Q
2021-02-10 10-K Annual Report – 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2021-11-29 2,036,269 18,957,133 10.74
2021-11-26 3,380,810 12,361,750 27.35
2021-11-24 1,193,653 13,521,540 8.83

(click for more detail)

(click for list of largest short owners)

Similar Companies
AMRX – Amneal Pharmaceuticals Inc BHC – BauschHealth?Companies?Inc.
BHVN – Biohaven Pharmaceutical Holding Co Ltd CPSR – Capstar Special Purpose Acquisition Corp
CPSR.U – Capstar Special Purpose Acquisition Corp. Units, each consisting of one share of Class A Common Stoc


Financial data and stock pages provided by
Fintel.io





2018/07/06
> Back to All Posts